These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
74 related articles for article (PubMed ID: 11558259)
1. [Structural-functional study of recombinant forms of onconase]. Vorob'ev II; Ponomarenko NA; Durova OM; Kozyr' AV; Demin AV; Kolesnikov AV; Sashchenko LP; Karpeĭskiĭ MIa; Gabibov AG Bioorg Khim; 2001; 27(4):257-64. PubMed ID: 11558259 [TBL] [Abstract][Full Text] [Related]
2. Role of the N terminus in RNase A homologues: differences in catalytic activity, ribonuclease inhibitor interaction and cytotoxicity. Boix E; Wu Y; Vasandani VM; Saxena SK; Ardelt W; Ladner J; Youle RJ J Mol Biol; 1996 Apr; 257(5):992-1007. PubMed ID: 8632481 [TBL] [Abstract][Full Text] [Related]
3. Single amino acid substitutions at the N-terminus of a recombinant cytotoxic ribonuclease markedly influence biochemical and biological properties. Newton DL; Boque L; Wlodawer A; Huang CY; Rybak SM Biochemistry; 1998 Apr; 37(15):5173-83. PubMed ID: 9548748 [TBL] [Abstract][Full Text] [Related]
4. Expression and characterization of a cytotoxic human-frog chimeric ribonuclease: potential for cancer therapy. Newton DL; Xue Y; Boqué L; Wlodawer A; Kung HF; Rybak SM Protein Eng; 1997 Apr; 10(4):463-70. PubMed ID: 9194172 [TBL] [Abstract][Full Text] [Related]
5. Removal of N-terminal methionine from recombinant proteins by engineered E. coli methionine aminopeptidase. Liao YD; Jeng JC; Wang CF; Wang SC; Chang ST Protein Sci; 2004 Jul; 13(7):1802-10. PubMed ID: 15215523 [TBL] [Abstract][Full Text] [Related]
6. The structural integrity exerted by N-terminal pyroglutamate is crucial for the cytotoxicity of frog ribonuclease from Rana pipiens. Liao YD; Wang SC; Leu YJ; Wang CF; Chang ST; Hong YT; Pan YR; Chen C Nucleic Acids Res; 2003 Sep; 31(18):5247-55. PubMed ID: 12954760 [TBL] [Abstract][Full Text] [Related]
7. Onconase: an unusually stable protein. Notomista E; Catanzano F; Graziano G; Dal Piaz F; Barone G; D'Alessio G; Di Donato A Biochemistry; 2000 Aug; 39(30):8711-8. PubMed ID: 10913282 [TBL] [Abstract][Full Text] [Related]
8. Effective expression and purification of recombinant onconase, an antitumor protein. Notomista E; Cafaro V; Fusiello R; Bracale A; D'Alessio G; Di Donato A FEBS Lett; 1999 Dec; 463(3):211-5. PubMed ID: 10606723 [TBL] [Abstract][Full Text] [Related]
10. The importance of dynamic effects on the enzyme activity: X-ray structure and molecular dynamics of onconase mutants. Merlino A; Mazzarella L; Carannante A; Di Fiore A; Di Donato A; Notomista E; Sica F J Biol Chem; 2005 May; 280(18):17953-60. PubMed ID: 15728177 [TBL] [Abstract][Full Text] [Related]
11. Enzymatic and structural characterisation of amphinase, a novel cytotoxic ribonuclease from Rana pipiens oocytes. Singh UP; Ardelt W; Saxena SK; Holloway DE; Vidunas E; Lee HS; Saxena A; Shogen K; Acharya KR J Mol Biol; 2007 Aug; 371(1):93-111. PubMed ID: 17560606 [TBL] [Abstract][Full Text] [Related]
12. [Effective expression of ribonuclease-onconase in Escherichia coli and assaying its cytotoxic potential]. Xu GF; Wang QC; Gong XG; Fei J Shi Yan Sheng Wu Xue Bao; 2004 Jun; 37(3):227-31. PubMed ID: 15323425 [TBL] [Abstract][Full Text] [Related]
13. Contribution of chain termini to the conformational stability and biological activity of onconase. Notomista E; Catanzano F; Graziano G; Di Gaetano S; Barone G; Di Donato A Biochemistry; 2001 Aug; 40(31):9097-103. PubMed ID: 11478876 [TBL] [Abstract][Full Text] [Related]
14. Onconase and amphinase, the antitumor ribonucleases from Rana pipiens oocytes. Ardelt W; Shogen K; Darzynkiewicz Z Curr Pharm Biotechnol; 2008 Jun; 9(3):215-25. PubMed ID: 18673287 [TBL] [Abstract][Full Text] [Related]
15. Quantitative analysis, using MALDI-TOF mass spectrometry, of the N-terminal hydrolysis and cyclization reactions of the activation process of onconase. Ribó M; Bosch M; Torrent G; Benito A; Beaumelle B; Vilanova M Eur J Biochem; 2004 Mar; 271(6):1163-71. PubMed ID: 15009195 [TBL] [Abstract][Full Text] [Related]
16. Molecular determinants of apoptosis induced by the cytotoxic ribonuclease onconase: evidence for cytotoxic mechanisms different from inhibition of protein synthesis. Iordanov MS; Ryabinina OP; Wong J; Dinh TH; Newton DL; Rybak SM; Magun BE Cancer Res; 2000 Apr; 60(7):1983-94. PubMed ID: 10766189 [TBL] [Abstract][Full Text] [Related]
17. A cytotoxic ribonuclease. Study of the mechanism of onconase cytotoxicity. Wu Y; Mikulski SM; Ardelt W; Rybak SM; Youle RJ J Biol Chem; 1993 May; 268(14):10686-93. PubMed ID: 8486718 [TBL] [Abstract][Full Text] [Related]
18. Localization and analysis of nonpolar regions in onconase. Kolbanovskaya EY; Terwisscha van Scheltinga AC; Mukhortov VG; Ardelt W; Beintema JJ; Karpeisky MY Cell Mol Life Sci; 2000 Aug; 57(8-9):1306-16. PubMed ID: 11028920 [TBL] [Abstract][Full Text] [Related]
19. Arginine residues are more effective than lysine residues in eliciting the cellular uptake of onconase. Sundlass NK; Raines RT Biochemistry; 2011 Nov; 50(47):10293-9. PubMed ID: 21980976 [TBL] [Abstract][Full Text] [Related]
20. Effect of N-terminal and Met23 mutations on the structure and dynamics of onconase. Gorbatyuk VY; Tsai CK; Chang CF; Huang TH J Biol Chem; 2004 Feb; 279(7):5772-80. PubMed ID: 14645226 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]